Infliximab for moderate to severe ulcerative colitis: the jury isn't in yet

Gastroenterology. 2014 Aug;147(2):544-5. doi: 10.1053/j.gastro.2014.02.060. Epub 2014 Jun 25.

Authors

Nagesh Kamath¹, Asha Kamath², C Ganesh Pai¹

Affiliations

¹ Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
² Department of Community Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.

PMID: 24973682
DOI: 10.1053/j.gastro.2014.02.060

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Azathioprine / therapeutic use*
Colitis, Ulcerative / drug therapy*
Female
Humans
Immunosuppressive Agents / therapeutic use*
Induction Chemotherapy / methods*
Male

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Immunosuppressive Agents
Azathioprine